Sign in

Emma Zhu

Vice President and Equity Research Analyst at Bank of America Securities

Emma Zhu is a Vice President and Equity Research Analyst at Bank of America Securities, specializing in covering US pharmaceutical and biotechnology companies, including notable firms such as Johnson & Johnson, Pfizer, Merck, and Amgen. She has earned recognition for the accuracy of her industry forecasts and investment recommendations, consistently ranking as a top analyst on platforms such as TipRanks, with a reported success rate above 70% and competitive average returns for her calls. Having joined Bank of America Securities in 2017 following earlier roles at Citigroup and Morgan Stanley, Zhu holds FINRA Series 7, 63, and 86/87 licenses and is registered with the SEC. Her achievements include multiple honors for her sector insight and contributions to institutional client strategies.

Emma Zhu's questions to Futu Holdings (FUTU) leadership

Question · Q3 2025

Emma Zhu inquired about Futu's sensitivity to a Fed rate cut and the notable quarter-over-quarter and year-over-year increases in R&D and G&A costs. She asked for the company's target or plan for investments in crypto and AI capabilities, which were cited as primary drivers for R&D, and for G&A staff increases.

Answer

CFO Arthur Chen explained that a 25 basis point Fed rate cut would negatively impact monthly pre-tax profit by approximately HKD 7 million, though positive factors like increased trading velocity and client asset inflows could partially offset this. Regarding expenses, he noted G&A increases were due to front-loading costs for new market preparations and crypto system investments for license applications. R&D increases were driven by crypto and AI investments, with plans to optimize AI capabilities for client agents and internal operating efficiency.

Ask follow-up questions

Fintool

Fintool can predict Futu Holdings logo FUTU's earnings beat/miss a week before the call

Question · Q3 2025

Emma Zhu asked about the sensitivity of Futu's financials to a Fed rate cut and sought clarification on the notable quarter-over-quarter and year-over-year increases in R&D and G&A expenses, specifically regarding investment plans for Crypto, AI capabilities, and general administrative headcount.

Answer

CFO Arthur Chen explained that a 25 basis points Fed rate cut would negatively impact monthly pre-tax profit by approximately HKD 7 million, though this could be partially offset by increased trading velocity and client asset inflows. He attributed the G&A expense increase to front-loading costs for new market preparations and investments in Crypto systems for license applications. R&D expenses were driven by optimizing AI capabilities for client agents and internal process streamlining.

Ask follow-up questions

Fintool

Fintool can write a report on Futu Holdings logo FUTU's next earnings in your company's style and formatting

Let Fintool AI Agent track Emma Zhu for you

Get briefed when they ask questions on calls

Best AI Agent for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Try Fintool for free